[EN] IL4I1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS D'IL4I1 ET PROCÉDÉS D'UTILISATION
申请人:MERCK SHARP & DOHME
公开号:WO2021226003A1
公开(公告)日:2021-11-11
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as IL4I1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for IL4I1-related diseases.
N-1- or N-3-substituted thieno[2,3-d]imidazol-2-one derivatives are selectively obtained after N-alkylation of thiaisatoic anhydrides followed by formation of the N-substituted aminocarbonyl azides and Curtius rearrangement, (C) 1999 Elsevier Science Ltd. All rights reserved.